Helen Mann
4PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 18, 2024
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer.Fabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg
|Oct 06, 2023
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.Luis Paz-Ares, Marina Chiara Garassino, Yuanbin Chen
|Oct 01, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON Study.Jimmy Zhijian He, Vincent Duval, Petra Jauslin
|Dec 17, 2017
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI.Helen Mann, Frank Andersohn, Carolyn Bodnar
Pageof 1
Frequent Collaborators
1 joint publications
Vincent Duval
1 joint publications
Cecil Chen
1 joint publications
Alex Phipps
1 joint publications
Diansong Zhou
1 joint publications
Luis Paz-Ares
1 joint publications
Marina Chiara Garassino
1 joint publications
Yuanbin Chen
1 joint publications
Niels Reinmuth
1 joint publications
Katsuyuki Hotta
1 joint publications
Artem Poltoratskiy
